Introduction {#S1}
============

Family-based linkage analysis has largely been supplanted by genome-wide association studies, often using unrelated samples, following the limited success of linkage when applied to complex traits. Family-based analyses, however, have inherent strengths which complement other approaches for identification of contributors to complex phenotypes^[@R1],[@R2]^. Such analyses may be especially applicable to identifying low frequency (minor allele frequency \[MAF\] 0.01--0.05) to rare (MAF \< 0.01) alleles with high impact^[@R3]--[@R8]^. We have implemented approaches in parallel which utilize simple two-point linkage analysis and conventional association analysis to search for genetic variants with meaningful contributions to phenotypic variance of traits. Two-point linkage analysis considers each variant independently, unlike multipoint analysis which integrates the information from multiple variants simultaneously. Therefore, two-point linkage does not have the same issues with inflation due to linkage disequilibrium between markers and can be used to test putatively impactful variants for linkage directly. The combined two-point linkage and association approach has the advantage of being able to directly align SNP results for the two analyses, pinpointing variants which show evidence of both linkage and association at the single SNP level. In prior studies, this has been applied to exome chip data, thus focusing on coding variants^[@R9]^ and characteristics of a functional SNP^[@R10]^.

Evaluation of association in the context of linkage has an extensive history^[@R11]--[@R13]^, with association typically utilized to determine whether genetic variants residing under the linkage peak explain the observed signal. We have observed that instances of strong linkage and association together at a single locus (e.g. APOE with ApoB levels, CETP with HDL levels, ADIPOQ with adiponectin levels)^[@R9],[@R10]^ represent variants or loci which have a striking impact on phenotype, reflected as explanation of a high proportion of the variance of the trait (3--60%). We have also observed this across a range of minor allele frequencies (1--45%), indicating that this approach can be informative for a full range of genetic variation. Other groups have utilized combined metrics of linkage and association to identify variants with large impact^[@R11]^; however, that is a project currently undergoing evaluation separate from these analyses.

Here we have investigated the performance of these approaches in a contemporary genetic dataset consisting of comprehensive genome-wide and exome chip data encompassing 1.6 million SNPs in 90 Hispanic families from the Insulin Resistance Atherosclerosis Family Study (IRASFS). Based on our prior work and recent evidence for the existence of high impact non-coding variants^[@R14]^, we hypothesize this family-based method is applicable to the search for such variants.

Materials and Methods {#S2}
=====================

Samples and Phenotype Data {#S3}
--------------------------

The samples used in this study are from the Hispanic cohorts of the Insulin Resistance and Atherosclerosis Family Study (IRASFS)^[@R15]^. Briefly, subjects were ascertained on the basis of large family size in San Luis Valley, Colorado and San Antonio, Texas. The sample consisted of 1 425 individuals from 90 families, who were extensively phenotyped, including a frequently sampled intravenous glucose test (FSIGT), measures of blood lipids and inflammatory markers, anthropomorphic measures, as well as fat deposition measures by computed tomography (CT) and dual X-ray absorptiometry (DXA) scans. IRB approval was obtained at all clinical and analysis sites, and all participants provided informed consent.

Genotype Data {#S4}
-------------

SNP genotype data from three genotyping chips were utilized. Illumina OmniExpress and Illumina Omni 1S chips were genotyped as part of the Genetics Underlying Diabetes in Hispanics (GUARDIAN) Consortium (N = 1034 and 1038, respectively)^[@R16]^, and the Illumina HumanExome Beadchip was genotyped on a larger subset (N = 1414)^[@R9]^ of the full IRASFS Hispanic cohorts. Genotyping of the Illumina HumanExome BeadChip v1.0 (N = 552) and v1.1 (N = 862) was performed at the Wake Forest Center for Genomics and Personalized Medicine Research, while the Illumina HumanOmniExpress BeadChip and Illumina Omni1S BeadChip were genotyped at the core genotyping laboratory at Cedars-Sinai Medical Center. All genotypes were called separately by genotyping array using GenomeStudio (Illumina, San Diego, CA). Sample and autosomal SNP call rates were ≥0.98 (\>0.99 SNP call rates for the OmniExpress and Omni1S chips), and Exome Chip SNPs with poor cluster separation (\<0.35) were excluded. All datasets independently underwent Mendelian error checking using PedCheck^[@R17]^ to detect genotypes discordant in families for Mendelian inheritance, with resolution by removing all inconsistent genotypes. The total number of unique SNPs available for analysis following QC was as follows: 81 559 from the Exome Chip, 668 758 from OmniExpress and 920 823 from the Omni1S chip, for a total of 1 671 140 SNPs.

Imputation to the 1000 Genomes integrated reference panel (version 2) was performed using genotypes and samples from the OmniExpress dataset (N = 634K genotypes and 1034 individuals) using SHAPEIT^[@R18]^ for phasing and IMPUTE2^[@R19]^ for imputation.

Analyses {#S5}
--------

SNPs were evaluated for both two-point family-based linkage and single SNP association using Sequential Oligogenic Linkage Analysis Routines (SOLAR)^[@R20]^ separately by genotyping platform. Both analyses used age, sex, body mass index (BMI), and study center as covariates. All phenotypes evaluated were transformed to approximate normality of the residuals if necessary ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Additionally, due to the high impact of a low frequency variant known to influence adiponectin levels in this population^[@R3],[@R10]^, presence of the variant encoding the G45R missense mutation in *ADIPOQ* (rs200573126) was included as a covariate for analyses involving adiponectin. Visceral adipose tissue area (VAT), visceral to subcutaneous tissue ratio (VSR), waist circumference, and waist-to-hip ratio (WHR) were run both with and without BMI as a covariate. However subcutaneous adipose tissue area (SAT), percent body fat, and body adiposity index (BAI) were not adjusted for BMI. All association analyses included three admixture proportions as covariates. Existing admixture proportion estimates were available from previously genotyped exome chip data; estimates were computed by maximum likelihood estimation of individual ancestries in ADMIXTURE^[@R21]^ assuming five ancestral populations (K = 5) from exome chip-wide SNP data after pruning for linkage disequilibrium (LD) to produce admixture estimates for the greatest number of samples. Of the five variables considered, three variables were selected as representing the variation in these Hispanic samples, as inclusion of additional postulated ancestral populations began isolating individual pedigrees.

For validation of performance, genotypes imputed to the 1000 Genomes panel were also evaluated for linkage (and association) in two regions which were selected for their linkage regions as well as being phenotypically of particular interest to our group: chromosome 1 for acute insulin response to glucose (AIR) and chromosome 7 for insulin sensitivity index (S~I~). Best guess genotypes from the imputed data were used in the linkage analysis because methods that account for imputation uncertainty have not been developed for linkage. These analyses used the same covariates as previously mentioned.

Results {#S6}
=======

The goal of this analysis was to test the utility of carrying out a combined linkage and association analysis in a contemporary dataset made up of GWAS (Illumina OmniExpress and Omni1S) and exome chip data encompassing over 1.6 million SNPs. The combined performance was evaluated for a total of 50 quantitative traits from 7 phenotypic groups: Glucose Homeostasis, Adiposity, Lipids, Biomarkers, Hypertension, Liver Enzymes, and Liver Fat, in 90 families from the IRASFS with an average family size of 15.4 individuals. Overall, 83 557 000 LOD scores and association p-values were calculated across the three genotyping sets.

Characteristics of the samples and genotyping are summarized in [Table 1](#T1){ref-type="table"}. The sample consisted of 1418 individuals from 90 families. Specifically, for the smallest genotyped sample (OmniExpress), sample sizes ranged from 786 (percent body fat) to 1034 (AIR), although larger sample sizes were available for SNPs present on the exome chip (up to 1256 for fibrinogen and ACR). Across all phenotypes, there were 9214 LOD scores greater than or equal to 3, 845 ≥ 4 and 89 ≥ 5. Of the 57 variants with LOD scores greater than 5.0, 27 were linked to TNFα receptor 2 levels, 13 to HDL levels, 5 to AIR, 4 to G45R-adjusted adiponectin levels, and three to BMI-adjusted VAT. While a detailed summary of each trait analysis is impractical, following on our earlier observations^[@R9],[@R10]^, we have initially focused on the patterns visible in linkage analysis followed by relating these results to association analysis results. In this report, we evaluated linkage and association with 50 cardiometabolic phenotypes (see [Supplementary Table 1](#SD1){ref-type="supplementary-material"} for complete listing). Selected phenotypes, namely TNFα receptor 2 levels, high density lipoprotein (HDL) levels, AIR, adiponectin levels (adjusted for G45R, a high impact mutation identified previously in these samples^[@R3],[@R10]^), and VAT adjusted for BMI are summarized in [Table 1](#T1){ref-type="table"}. Overall, 12 phenotypes (from 4 phenotype groups: glucose homeostasis, lipids, adiposity and biomarkers) were represented in this category of LOD \> 5.0 results summarized in [Table 2](#T2){ref-type="table"}, where highest LOD scores are grouped by phenotype and chromosome. A complete summary of LOD scores greater than 5 is presented in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}.

Evaluation of loci with high LOD scores {#S7}
---------------------------------------

The overall maximal LOD score of 6.49 was observed with rs12956744 with the biomarker TNFα receptor 2 levels ([Table 3](#T3){ref-type="table"}; [Figure 1a](#F1){ref-type="fig"}). This SNP is located in intron 1 (nearer the 5′ end) of *LAMA1* (laminin subunit alpha-1 gene) on chromosome 18. Of note, three additional intronic variants in *LAMA1* were also linked to TNFα receptor 2 levels with LOD \> 6, and 9 SNPs overall were linked with LOD \> 3 ([Table 3](#T3){ref-type="table"}). Notably, one SNP (rs28569884) was also associated with TNFα receptor 2 levels (p-value = 5.9×10^−4^; LOD = 1.06). The variant rs28569884 (in intron 56) is distal to the striking linkage signal (146 kb apart), though there was another LOD score over 4 (rs4395154; LOD = 4.47) just 13 kb away at the 3′ end of the *LAMA1* gene (intron 62). *LAMA1* is a very large gene, with 63 exons and 245 SNPs analyzed. Of these, 11 (4.4%) had nominally significant association (p-value \< 0.05) with TNFα receptor 2 levels. Comparatively, 9 variants had LOD scores greater than 3 (3.7%) and 23 variants had LOD scores greater than 1 (9.4%).

A major focus of our laboratory is identifying genetic contributors to metabolic measures of glucose homeostasis. The top linkage result of LOD = 6.47 ([Table 4](#T4){ref-type="table"}) for AIR was rs28479408, an intronic variant located in *SYCP2L* (synaptonemal complex protein 2-like gene) on chromosome 6 ([Figure 1b](#F1){ref-type="fig"}). Although this variant was not associated with AIR (p-value = 0.71), six other SNPs in this gene were also linked (rs4713044, LOD = 6.10; rs12190237, LOD = 5.58; rs12214063, LOD = 3.58; rs1767771, LOD = 3.42; rs2153159, LOD = 3.31; rs1632103, LOD = 3.15) but not associated (p-values \> 0.5) ([Table 4](#T4){ref-type="table"}).

Strikingly, chromosome 1 had a broad linkage peak for AIR, with a maximal LOD score of 6.37 (rs2252384) in the region between *FAM163A* and *TOR1AIP2* (located at approximately 179 Mb; 1q25.2; [Figure 1b](#F1){ref-type="fig"}; [Table 5](#T5){ref-type="table"}). Chromosome 1 has a long history of linkage to diabetes, making this result all the more interesting^[@R22]--[@R25]^. Here, variants with LOD scores greater than three spanned much of the proximal q arm of the chromosome, with the most concentrated linkage peak residing between 156Mb and 187 Mb, a region encompassing 357 RefSeq genes (1q22--31.1). Focusing on the peak LOD-1 substantially narrowed the region to a very narrow 1.57 Mb. Of the 343 variants within this region with LOD scores greater than 3, 73 of them had p-values less than 0.05, with a best association signal occurring at rs6426957 (Chr1:165988336; p-value = 6.34×10^−4^, LOD = 3.09, MAF = 0.441; [Supplementary Table 3](#SD1){ref-type="supplementary-material"}). Notably, many variants within *RASAL2* (RAS protein activator like 2 gene) showed nominal evidence of association (0.05 \> p-value \> 1.42×10^−3^) in addition to linkage (N = 45 of 46 linked \[LOD\>3\] SNPs; [Tables 5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}). LOD scores at this gene ranged from 3.00--5.38.

Additional linkage results of interest include regions on chromosomes 7 and 12 which were linked to insulin sensitivity index (S~I~). Although these regions did not reach the magnitude seen for TNFα receptor 2 and AIR, the consistency of linkage in the region is compelling. On chromosome 7, the highest LOD score (5.11) was seen with rs1024591, an intergenic SNP over 300kb from the nearest gene (a long intergenic non-coding RNA, *LINC01372*) ([Supplementary Table 4](#SD1){ref-type="supplementary-material"}). The linkage signal on chromosome 12 is made up of two distinct peaks ([Figure 1c](#F1){ref-type="fig"}), one at \~53Mb and the second at \~105 Mb ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}). The LOD scores seen here are not as striking by magnitude (max LOD for each peak 4.27--4.28), but the consistency of LOD scores over 3 into tight peaks is notable ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}). The first peak consists of 14 variants with LOD scores over 3, from 50.6--54.5Mb, with multiple variants in the *KRT8* (keratin 8 gene) and *ESPL1* (extra spindle pole bodies like 1, separase) showing evidence for linkage, as well as single variants at the proximal end of the peak in *LIMA1* (LIM domain and actin binding 1 gene), *DIP2B* (disco interacting protein 2 homolog B gene), and *SLC4A8* (solute carrier family 4, sodium bicarbonate cotransporter, member 8 gene). There was no evidence for association among linked variants at this linkage peak, though other, unlinked variants in the region showed nominal association ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}).

The second linkage peak resides from 101--109Mb on chromosome 12, and included 21 linked variants which represented multiple signals from *CHST11* (carbohydrate (chondroitin 4) sulfotransferase 11 gene), *ACACB* (acetyl-CoA carboxylase beta gene), and *FOXN4* (forkhead box N4 gene), in addition to intergenic variants and genes implicated by a single variant, such as *CMKLR1* (chemerin chemokine-like receptor 1 gene) ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}). One of these linked variants showed nominal evidence of association, with a p-value of 5.50×10^−3^ (rs11114094 in *SVOP* \[SV2 related protein gene\]; [Table 6](#T6){ref-type="table"}; [Supplementary Tables 3 and 5](#SD1){ref-type="supplementary-material"}), although like the prior peak, other unlinked variants in the linkage region also demonstrated evidence of association.

Variants with evidence of both linkage and association {#S8}
======================================================

Utilizing the linkage results as a search tool and prioritizing those with any evidence of association identified 1076 variants with p-values less than 0.05 as well as a LOD score greater than or equal to 3 ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). Twenty-seven variants were associated with p \< 0.005 as well as having a LOD score \> 4 ([Table 6](#T6){ref-type="table"}). *NFIB* was the primary gene implicated under a linkage peak with TNFα receptor 2 levels on chromosome 9, where there was also evidence of nominal association (p-values on the order of 2×10^−4^; [Figure 1a](#F1){ref-type="fig"}; [Supplementary Table 6](#SD1){ref-type="supplementary-material"}). *NFIB*, which encodes nuclear factor I/B, is represented by 293 SNPs (135 from OmniExpress; 157 from Omni 1S, 1 from exome chip), 289 of which were located in introns. Only one coding variant in this gene was polymorphic from the exome chip dataset, this SNP (rs114558598; I24F) was not linked (LOD = −0.005) or associated (p-value = 0.08). Ten common variants (0.27 \< MAF \> 0.49) within this gene (all intronic) had LOD scores greater than 3. Overall, 68 *NFIB* variants had LOD scores greater than 1, and 24 had LOD scores greater than 2.

*LPHN3* on chromosome 4 was a strong signal for LDL levels, with two intronic variants being both linked and associated (rs2343249; LOD = 4.30; p-value = 1.00×10^−5^ and rs9312078, LOD = 3.02; p-value = 8.20×10^−5^; [Table 7](#T7){ref-type="table"}; [Figure 1d](#F1){ref-type="fig"}). Both the linkage and association signals were confined to the gene region, with strong LD (r^2^ \> 0.8) between the two top SNPs. There was further support throughout the gene-encoding region for both modest linkage and association with diminishing LD ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). The strongest association result among LOD scores ≥ 3 was with fibrinogen levels; rs1131878 from the OmniExpress chip, LOD = 3.08 and p-value = 1.99×10^−6^ ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). This SNP was located within the *UGT2B4* gene, which encodes UDP glucuronosyltransferase 2 family polypeptide B4.

Discussion {#S9}
==========

This study evaluated the utility of combining two-point linkage with association analysis in a data set comprised of array-based SNP genotyping totaling 1.6 million non-coding and coding variants in a family-based sample of Hispanics with extensive phenotype information. The goal of the study was to evaluate whether GWAS data in the context of linkage adds insight into the genetic origins of cardiometabolic traits, while utilizing association analysis as a follow up to determine likely candidate loci. This builds upon our prior evaluation of combined linkage and association using exome chip data in this cohort^[@R9]^. Large-scale linkage analysis of SNP genotyping has been uncommon for complex phenotypes recently. To this end, we evaluated 50 phenotypes (46 distinct traits) related to glucose homeostasis, lipids, blood pressure, adiposity, liver fat and enzymes, and biomarkers. Given the breadth of genotypic data and number of phenotypes, the results are extensive, but some noteworthy observations can be made. Broadly speaking, we believe the markedly denser genotypic dataset reveals many insights into the genetic bases of the traits such as TNFα receptor 2, AIR, and S~I~ when compared to our prior study using the more limited data from the exome chip.

Relatively dense genotyping data provides visual evidence of linkage similar to conventional multipoint methods. In addition, while exome chip analysis primarily targets models where functional variants are exonic, the GWAS datasets can potentially address other models such as high impact non-coding variants, especially through linkage analysis. Here we have observed few examples where evidence for both linkage and association are apparent. An example is *LPHN3* ([Table 7](#T7){ref-type="table"}, [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}), where LOD scores reached 4.30 with a p-value of 1.00×10^−5^, suggesting a true impact on LDL levels. Given the actual low density of coverage in GWAS datasets which are designed to cover genomic regions through LD relationships, it is unlikely to capture truly causal variants by chance. The ultimate test of whether this approach will be successful will require whole genome sequencing data. Overall, these results incorporating two-point linkage and association analyses can identify meaningful signals that impact cardiometabolic traits, often in the absence of striking association alone. These conclusions are consistent with our prior work^[@R9],[@R10]^ in which we have shown that linkage evidence can be relatively strong, but association evidence only appears when the functional variant is also captured. The latter is unlikely in a GWAS dataset. For these reasons, our main focus was on regions with evidence of linkage based on both the power of linkage methods and the "far-sighted" ability of linkage to identify genetic relationships^[@R4]--[@R7],[@R9],[@R10]^.

As noted above, several genomic regions had relatively strong evidence of linkage, but limited association results. Based on our logic, this would suggest the possibility of underlying, as yet unidentified functional variants. Thus, for the strongest linkage with TNF2α receptor levels (LOD = 6.49) we would hypothesize that one or more high impact non-coding variants lie within the linkage region. *LAMA1* is similar to *LAMA5* which has previously been related to TNFRSF1B expression^[@R26]^, making it plausible for *LAMA1* to be related to TNF2α receptor levels.

Analysis of traits of interest to our laboratory (AIR, S~I~) also resulted in notable linkage peaks. It is tempting to scan these linked regions for biologically relevant genes. Genes located under a broad AIR linkage region on chromosome 1 ([Figure 1b](#F1){ref-type="fig"}, [Table 5](#T5){ref-type="table"}) included *FAM163A*, also known as neuroblastoma derived secretory protein (*NDSP*), *TOR1AIP2*, and *RASAL2. FAM163A* (aka *NDSP*) has been associated in methylation analysis for borderline personality disorder^[@R27]^ with overexpression observed in neuroblastoma^[@R28],[@R29]^. *TOR1AIP2* encodes torsin A interacting protein 2, which is involved in the nuclear envelope^[@R30],[@R31]^. Mutations in *TOR1AIP1* have been shown to cause muscular dystrophy^[@R32]^. *RASAL2* (RAS protein activator like 2) has been implicated as an obesity susceptibility gene in both Chinese^[@R33]^ and Mexican populations^[@R34]^, as well as having a role in the susceptibility of many cancers, including liver^[@R35]^, thyroid^[@R36]^, ovarian^[@R37]^, breast^[@R37],[@R38]^, and lung^[@R39]^.

Genes under the S~I~ linkage peaks also included interesting candidates. On chromosome 12, the most relevant gene with linkage in the distal linkage peak was *CMKLR1* (chemerin chemokine-like receptor 1), which is believed to play a role in glucose homeostasis^[@R40]--[@R42]^, obesity^[@R41],[@R43],[@R44]^ and diabetes development^[@R45]^. Of note, a strong association signal (p-value = 1×10^−7^) was also seen within this linkage peak in *WSCD2* (WSC domain containing 2; 100Mb from *CMKLR1*) ([Figure 1c](#F1){ref-type="fig"}).

Additional genes included *LIMA1* (LIM domain and actin binding 1, also known as *EPLIN* and *SREPB3*), a tumor suppressor; *DIP2B* (disco interacting protein 2 homolog B), replicated as a susceptibility locus for colorectal cancer^[@R46]^; and *SLC4A8*, a sodium bicarbonate transporter, which may have a role in regulation of blood pressure with some variants in this gene having been previously implicated^[@R47],[@R48]^. Further, *KRT8* (keratin 8, type II) which is overexpressed in human liver disease, resides under the linkage peak on 12q^[@R49]^. The linkage region on chromosome 7 contained only one putative gene, *LOC102723427*, about which there is no known information.

The most intriguing signal lies in *LPHN3* and was both linked and associated with LDL levels at two separate variants. This gene encodes latrophilin 3 (recently renamed as *ADGRL3*^[@R50]^; adhesion G protein-coupled receptor L3), which is related to latrotoxin, the toxin produced by the black widow spider^[@R51]^. There is evidence suggesting a role for latrophilin 3 (among other latrophilins) in binding to fibronectin leucine-rich transmembrane (FLRT) family members, which has been shown to promote the development of glutamatergic synapses^[@R52],[@R53]^. Additionally, genetic variants in *LPHN3* have been associated reproducibly with attention deficit hyperactivity disorder (ADHD) and other psychiatric conditions^[@R54]--[@R56]^. *LPHN3* is also being investigated as a pharmacogenetic target^[@R57]^. Despite the lack of biological evidence directly supporting the link between *LPHN3* variants and LDL cholesterol levels, cholesterol is crucially important in the brain, and further study may elucidate a mechanism by which genetic variants in *LPHN3* impact plasma LDL levels.

We previously reported *CETP* (cholesterol ester transfer protein) linkage and association with HDL levels in exome chip data from this Hispanic sample^[@R9]^. Linkage of *CETP* in this dataset was stronger with LOD scores of up to 5.43, an increase of 1.14 over the previous top signal ([Table 6](#T6){ref-type="table"}; [Supplementary Table 2](#SD1){ref-type="supplementary-material"}).The addition of GWAS data implicated additional linked variants (LOD \> 5, N = 4) proximal to the coding region, perhaps occluding interpretation of the functional impact of this linkage result.

Here we assessed the impact of SNP density to provide insight into linkage relationships with the conclusion that dense SNP maps do reveal additional insight. We have extended this query further by evaluation of imputed genotype data in regions of particular interest due to evidence of strong linkage with glucose homeostasis-related phenotypes. Three regions were selected based on substantial linkage evidence and a particular interest in glucose homeostasis: chromosome 1 with AIR and chromosomes 7 and 12 with S~I~. Utilization of imputed data increases the number of markers capturing the region by 22--fold (18 411 directly genotyped markers, 406K imputed markers). The maximal LOD score from the imputed AIR region was 6.45 at rs2252384 (the same SNP implicated in the directly genotyped data; [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). The slight increase in LOD score (6.37 to 6.45) can likely be attributed to more complete information following imputation of missing genotypes. For chromosome 7 with S~I~, a new best SNP rs2530421 had the maximum LOD score of 5.53 (compared to the prior best LOD of 5.11 at rs1024591). The imputed best SNP lies very near the original peak linkage, providing little additional guidance in refining the causal variant(s), given the high degree of correlation between the top linked SNPs (r^2^ = 0.937). Evaluation of another linked region (chromosome 12 with S~I~) also showed some limited improvement in linkage signals, but linkage signals were only modestly increased, as could be expected due to the information carried by these imputed markers being wholly derived from the genotyped markers which had already been informative. Thus, inclusion of imputed genotypes marginally improved the maximal LOD scores when evaluated in this small number of examples. However, the improvements did not further refine the regions of interest ([Supplementary Figure 2](#SD1){ref-type="supplementary-material"}).

In conclusion, we have built upon our previous analysis of combined two-point linkage and association^[@R9]^ and evaluated utility of the approach in a dataset comprised of comprehensive genome-wide array-based SNP genotypes. As seen previously, there were few examples in this data where linkage and association both provided striking evidence at the same locus, which, based on our prior analysis^[@R10]^, would implicate a likely ungentoyped causal variant. However, the GWAS plus exome chip design identified multiple additional regions of linkage which were not seen in exome chip analysis alone. Positive, strong evidence of association with SNPs was not observed, suggesting that functional variants, if they are indeed captured by the linkage signal, have not been identified. To truly test the broad utility of this approach, whole genome sequencing data will be necessary which will incorporate the full spectrum of variant frequencies.
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###### 

Demographic characteristics of the IRASFS Hispanic samples with selected phenotypes.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                           Exome Chip\         Omni Express\             Omni 1S\                                               
                                           (81 559 variants)   (668 758 variants)        (920 823 variants)                                     
  ---------------------------------------- ------------------- ------------------------- -------------------- ------------------------- ------- -------------------------
  Samples[1](#TFN2){ref-type="table-fn"}   1 414               1 034                     1 038                                                  

  Age (years)                              1 263               42.75 (18--81)            1 034                40.63 (18--81)            1 038   40.61 (18--81)

  \% Female                                823                 58.3 % F                  609                  58.90%                    612     58.90%

  BMI (kg/m^2^)                            1 253               28.88 (16--58)            1 027                28.28 (16--58)            1 027   28.28 (16--58)

  \% T2D[2](#TFN3){ref-type="table-fn"}    187                 13.20%                    0                    0%                        0       0%

  AIR (pmol\*mL-1\*min-1)                  1 035               761.86 (−80.9--4 313.7)   1 034                760.29 (−80.9--4 313.7)   1 038   759.21 (−80.9--4 313.7)

  TNFα receptor 2 (ng/mL)                  982                 7.05 (2.38--30.00)        821                  6.79 (2.38--30.00)        824     6.79 (2.38--30.00)

  Fibrinogen (mg/dL)                       1 256               265.74 (113--591)         1 032                259.37 (113--506)         1 036   259.61 (113--506)

  Cholesterol (mg/dL)                      1 255               177.94 (74--348)          1 031                176.12 (74--311)          1 035   176.17 (74--311)

  HDL (mg/dL)                              1 254               43.82 (18--125)           1 030                43.58 (18--100)           1 034   43.60 (18--100)

  LDL (mg/dL)                              1 242               109.17 (31--218)          1 022                109.04 (31--213)          1 026   109.06 (31--213)

  Triglycerides (mg/dL)                    1 252               124.57 (18--836)          1 030                118.30 (18--836)          1 034   118.31 (18--836)

  ACR (mg/g)                               1 256               53.55 (1.63--3 903.92)    1 032                19.63 (1.93--1 459.68)    1 036   19.58 (1.93--1 459.68)

  Percent Body Fat                         943                 33.95 (10.10--55.03)      786                  33.51 (10.10--51.78)      789     33.52 (10.10--51.78)

  VAT (cm^2^)                              1 206               114.02 (10.04--382.56)    994                  106.56 (10.04--363.34)    998     106.52 (10.04--363.34)

  VSR                                      1 164               0.38 (0.07--1.63)         963                  0.36 (0.07--1.56)         967     0.36 (0.07--1.56)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data presented as mean (range) or percent.

From 90 pedigrees, not entirely overlapping.

at baseline

###### 

Summary of linkage results for phenotypes with at least one variant with LOD \>4.

  Phenotype                                                LOD \> 5   LOD \> 4   LOD \> 3
  -------------------------------------------------------- ---------- ---------- ----------
  **Acute Insulin Response (AIR)**                         24         180        1 335
  **Insulin Sensitivity Index (S~I~)**                     1          17         247
  Disposition Index (DI)                                              8          101
  Metabolic Clearance Rate of Insulin (MCRI)                          6          100
  **Total Cholesterol**                                    1          16         269
  **High Density Lipoprotein (HDL)**                       13         129        1 202
  **Low Density Lipoprotein (LDL)**                        1          9          191
  Apolipoprotein B (ApoB)                                             9          291
  **Triglycerides**                                        4          18         151
  Systolic Blood Pressure (SBP)                                       1          48
  Diastolic Blood Pressure (DBP)                                      1          24
  Albumin/Creatinine Ratio (ACR)                                      3          169
  **Adiponectin (adjusted)**                               13         96         621
  C-Reactive Protein (CRP)                                            5          84
  Fibrinogen                                                          16         341
  **TNFα Receptor 2 (TNF2)**                               27         259        2 458
  Retinol Binding Protein 4 (RBP4)                                    1          20
  **Body Mass Index (BMI)**                                1          11         100
  Body Adiposity Index (BAI)                                          4          66
  **Percent Body Fat**                                     1          18         159
  Waist Circumference                                                 2          32
  Waist-to-Hip Ratio (WHR)                                            1          10
  **Subcutaneous Adipose Tissue (SAT)**                    1          7          151
  Visceral Adipose Tissue (adj. for BMI)                              1          63
  **Visceral-to-Subcutaneous Ratio (VSR)**                 1          8          138
  **Visceral-to-Subcutaneous Ratio (VSR; adj. for BMI)**   3          9          141
  Liver Density                                                       4          123
  Inverse Normalized Liver                                            2          47
  Gamma Glutamyl Transpeptidase (GGT)                                 6          126

Boldface indicates phenotypes with a LOD score \>5.

###### 

Selected *LAMA1* results with TNFα receptor 2 protein levels (LOD\>1 and/or P-value \<0.01)

  SNP          Chr   Position   Chip          N     MAF     LOD        P-value        Beta Value   Standard Error   Variance
  ------------ ----- ---------- ------------- ----- ------- ---------- -------------- ------------ ---------------- ----------
  rs4395154    18    6942805    OmniExpress   820   0.46    **4.47**   0.25           0.016        0.014            0.001
  rs2016639    18    6943264    OmniExpress   821   0.431   **3.46**   0.2            −0.018       0.014            0.002
  rs17439137   18    6951060    OmniExpress   821   0.235   1.07       0.77           −0.005       0.016            0
  rs8086875    18    6951710    Omni1S        821   0.208   1.15       0.36           0.015        0.017            0.0008
  rs8088218    18    6951971    Omni1S        820   0.21    1.62       0.32           0.017        0.017            0.001
  rs12454596   18    6953989    OmniExpress   821   0.446   1.85       0.73           0.005        0.014            0.0002
  rs949215     18    6955676    OmniExpress   821   0.25    1.18       0.96           0.001        0.016            0
  rs28569884   18    6956111    Omni1S        821   0.058   1.06       **5.94E-04**   −0.098       0.029            0.015
  rs509497     18    6957193    OmniExpress   821   0.393   1.29       **0.04**       0.028        0.014            0.005
  rs633691     18    6967089    OmniExpress   821   0.419   **3.18**   0.085          0.024        0.014            0.0044
  rs11873205   18    6979621    Omni1S        818   0.13    1.54       **0.0072**     −0.055       0.021            0.0113
  rs538815     18    6982443    OmniExpress   821   0.202   1.69       0.5            −0.011       0.017            0.0003
  rs619106     18    7011413    OmniExpress   821   0.291   0.03       **0.042**      −0.032       0.015            0.009
  rs67268419   18    7013648    Omni1S        820   0.077   1.74       0.74           −0.009       0.025            0.0006
  rs541928     18    7034932    Omni1S        821   0.153   2.05       0.49           0.013        0.019            0
  rs7240767    18    7070642    OmniExpress   821   0.468   0          **0.029**      −0.03        0.014            0.0058
  rs7228959    18    7076464    OmniExpress   821   0.49    0          **0.044**      −0.027       0.014            0.0047
  rs16951199   18    7080135    OmniExpress   815   0.068   0          **0.017**      −0.064       0.027            0.0081
  rs11081298   18    7085706    Omni1S        820   0.466   2.91       0.94           −0.001       0.014            0.0001
  rs12606163   18    7096977    OmniExpress   807   0.485   **4.78**   0.11           0.022        0.014            0.0038
  rs972038     18    7102036    Omni1S        816   0.171   0.07       **0.046**      −0.036       0.018            0.0103
  rs12955222   18    7102427    OmniExpress   821   0.482   **4.53**   0.13           0.02         0.013            0.0038
  rs12956744   18    7102706    Omni1S        821   0.407   **6.49**   **0.03**       0.03         0.014            0.0071
  rs12959835   18    7103146    Omni1S        820   0.408   **6.38**   **0.034**      0.029        0.014            0.0068
  rs1462780    18    7105988    OmniExpress   820   0.019   0          **0.034**      −0.103       0.049            0.0072
  rs34433741   18    7108999    Omni1S        820   0.415   **6.07**   0.089          0.023        0.014            0.0031
  rs4798533    18    7109571    Omni1S        819   0.282   1.52       0.82           −0.003       0.015            0.0002
  rs12454984   18    7109652    Omni1S        821   0.404   **6.02**   0.15           0.02         0.014            0.0019
  rs984355     18    7114212    OmniExpress   821   0.217   2.55       0.36           0.016        0.017            0

Boldface indicates LOD scores \> 3 or p-values \< 0.05.

###### 

Chromosome 6 AIR linkage peak with linked (LOD\>3) and/or associated (p-value \<0.05) variants.

  SNP           Chr.   Position   Chip          N       MAF     Gene         LOD        P-value        Beta Value   Standard Error   Variance
  ------------- ------ ---------- ------------- ------- ------- ------------ ---------- -------------- ------------ ---------------- ----------
  rs12208366    6      10383410   Omni1S        1 034   0.146                **3.43**   0.578          0.39         0.701            0
  rs480965      6      10387251   OmniExpress   1 033   0.142                **3**      0.546          0.419        0.695            0
  rs533558      6      10395572   OmniExpress   1 033   0.406                **3.55**   0.122          −0.771       0.499            0.002
  rs79025376    6      10400618   Omni1S        1 033   0       *TFAP2A*     0          **5.06E-03**   −27.514      9.816            0.008
  rs78497087    6      10471612   Omni1S        1 032   0.356                **3.39**   0.813          0.123        0.518            0
  rs491803      6      10477438   Omni1S        1 033   0.331                **3.31**   0.885          0.075        0.521            0
  rs9466917     6      10606584   Omni1S        1 033   0.492   *GCNT2*      **3.32**   0.89           0.069        0.501            0
  rs3798704     6      10615268   Omni1S        1 034   0.494   *GCNT2*      **3.33**   0.923          0.048        0.5              0
  rs1233887     6      10739432   OmniExpress   1 033   0.36                 **3.1**    0.714          −0.187       0.51             0
  rs518954      6      10791859   OmniExpress   1 029   0.278   *MAK*        **3.1**    0.184          0.727        0.546            0.003
  rs12214063    6      10855738   Omni1S        1 032   0.213   *SYCP2L*     **3.58**   0.753          −0.195       0.62             0
  rs1767771     6      10857646   Omni1S        1 034   0.473   *SYCP2L*     **3.42**   0.685          −0.203       0.499            0
  rs1632103     6      10862649   Omni1S        1 034   0.478   *SYCP2L*     **3.15**   0.558          −0.293       0.5              0
  rs2153159     6      10887932   Omni1S        1 033   0.36    *SYCP2L*     **3.31**   0.969          −0.02        0.506            0
  rs4713044     6      10911282   OmniExpress   1 033   0.182   *SYCP2L*     **6.1**    0.951          −0.039       0.63             0
  rs28479408    6      10912131   Omni1S        1 034   0.177   *SYCP2L*     **6.47**   0.712          −0.236       0.64             0
  rs12190237    6      10922638   OmniExpress   1 031   0.164   *SYCP2L*     **5.58**   0.775          0.188        0.66             0
  rs6457131     6      11227328   OmniExpress   1 029   0.207   *NEDD9*      **3.24**   0.919          0.061        0.604            0
  rs55813531    6      11238023   Omni1S        1 031   0.185   *NEDD9*      **5.14**   0.274          0.698        0.639            0.002
  rs17496723    6      11238633   Omni1S        1 031   0.413   *NEDD9*      1.2        **7.89E-03**   −1.323       0.498            0.004
  rs9468690     6      11239119   OmniExpress   1 033   0.455   *NEDD9*      0.86       **7.86E-03**   −1.316       0.495            0.005
  rs9461574     6      11239518   OmniExpress   1 033   0.492   *NEDD9*      1.94       **5.77E-03**   −1.354       0.49             0.006
  rs12209631    6      11242203   OmniExpress   1 028   0.175   *NEDD9*      **3.08**   0.0873         1.134        0.662            0.005
  rs6908326     6      11247387   OmniExpress   1 033   0.204   *NEDD9*      2.97       **5.11E-03**   1.683        0.6              0.009
  rs10947066    6      11253969   Omni1S        1 034   0.264   *NEDD9*      **4.34**   **0.0468**     1.117        0.562            0.007
  rs10947067    6      11253990   Omni1S        1 033   0.265   *NEDD9*      **4.25**   **0.0481**     1.113        0.563            0.006
  rs6457197     6      11254692   Omni1S        1 028   0.496   *NEDD9*      **3.72**   **0.0165**     −1.176       0.491            0.01
  rs6457202     6      11255770   Omni1S        1 033   0.445   *NEDD9*      **4.29**   **8.71E-03**   1.324        0.505            0.013
  rs7766626     6      11256000   OmniExpress   1 031   0.371   *NEDD9*      **3.73**   **0.0152**     1.206        0.496            0.01
  rs210903      6      11724542   OmniExpress   1 031   0.271   *C6orf105*   **3.93**   0.954          −0.032       0.561            0
  rs4713831     6      11726626   OmniExpress   1 014   0.298   *C6orf105*   **4.12**   0.726          0.189        0.541            0
  rs210897      6      11729299   Omni1S        1 034   0.282   *C6orf105*   **5.49**   0.893          0.075        0.557            0
  rs114551218   6      11736145   Omni1S        1 030   0.003   *C6orf105*   0          **3.48E-03**   13.077       4.476            0.014
  rs210890      6      11740036   OmniExpress   1 032   0.162   *C6orf105*   **3.13**   0.552          0.4          0.673            0
  rs12204492    6      11774626   OmniExpress   1 032   0.424   *C6orf105*   **3.62**   0.376          −0.431       0.487            0.001
  rs2235384     6      11776631   OmniExpress   1 031   0.205   *C6orf105*   **3.02**   0.481          0.419        0.594            0

Boldface indicates LOD scores \> 3 or p-values \< 0.05.

###### 

Broad linkage region on Chromosome 1 with Acute Insulin Response: Variants with LOD \>4.5

  SNP          Chr.   Position    Chip          N       MAF     Gene             LOD        P-value        Beta Value   Standard Error   Variance Explained (association)
  ------------ ------ ----------- ------------- ------- ------- ---------------- ---------- -------------- ------------ ---------------- ----------------------------------
  rs12047043   1      164625696   OmniExpress   1 029   0.225   *AX748175*       **4.95**   0.16           0.832        0.594            0.005
  rs4657367    1      164627551   OmniExpress   1 033   0.225   *AX748175*       **4.72**   0.15           0.857        0.591            0.005
  rs4656475    1      166004063   Omni1S        1 032   0.14    Intergenic       **4.66**   0.38           0.635        0.721            0.001
  rs6662013    1      166042658   Omni1S        1 034   0.247   *FAM78B*         **5.19**   0.71           −0.21        0.565            0
  rs6680174    1      166459849   OmniExpress   1 033   0.266   Intergenic       **4.73**   0.33           0.544        0.553            0.001
  rs1476076    1      167794511   Omni1S        1 031   0.467   *ADCY10*         **4.74**   0.81           −0.113       0.48             0
  rs203849     1      167849414   OmniExpress   1 033   0.484   *ADCY10*         **4.62**   0.43           −0.395       0.5              0.002
  rs4656148    1      168179545   Omni1S        1 031   0.273   Intergenic       **4.87**   0.42           0.427        0.535            0
  rs11589732   1      168585289   OmniExpress   1 033   0.228   Intergenic       **5.00**   0.86           0.106        0.582            0
  rs7474070    1      171050589   OmniExpress   1 033   0.22    Intergenic       **4.86**   0.11           −0.959       0.597            0.003
  rs16863990   1      171055570   OmniExpress   1 032   0.193   Intergenic       **5.09**   0.15           −0.929       0.644            0.003
  rs12402693   1      171057312   OmniExpress   1 032   0.193   Intergenic       **5.16**   0.14           −0.947       0.643            0.003
  rs12404183   1      171058946   OmniExpress   1 026   0.212   Intergenic       **4.59**   0.21           −0.754       0.603            0.002
  rs1800822    1      171076935   OmniExpress   1 029   0.201   *FMO3*           **4.62**   0.3            −0.637       0.613            0.002
  rs2281002    1      171080629   OmniExpress   1 033   0.189   *FMO3*           **4.79**   0.12           −1.005       0.646            0.004
  rs909529     1      171082896   OmniExpress   1 033   0.201   *FMO3*           **4.72**   0.078          −1.103       0.624            0.004
  rs6659102    1      176535567   OmniExpress   1 032   0.149   *PAPPA2*         **4.66**   0.91           −0.082       0.685            0
  rs7540152    1      176656255   OmniExpress   1 033   0.13    *PAPPA2*         **4.53**   0.73           0.256        0.731            0
  rs791031     1      176667810   OmniExpress   1 030   0.129   *PAPPA2*         **4.60**   0.82           0.165        0.734            0
  rs11583320   1      178042145   OmniExpress   1 029   0.221   Intergenic       **4.52**   **5.63E-03**   1.597        0.576            0.006
  rs964993     1      178062359   OmniExpress   1 033   0.188   *LOC100302401*   **4.67**   **1.89E-03**   1.988        0.639            0.007
  rs10913506   1      178092233   OmniExpress   1 033   0.186   *RASAL2*         **4.93**   **1.52E-03**   2.019        0.636            0.008
  rs10798604   1      178254568   OmniExpress   1 029   0.174   *RASAL2*         **4.96**   **0.033**      1.38         0.648            0.004
  rs77603205   1      178279051   Omni1S        1 033   0.173   *RASAL2*         **4.52**   **0.021**      1.504        0.652            0.005
  rs10913550   1      178408795   OmniExpress   1 033   0.174   *RASAL2*         **5.16**   **0.027**      1.435        0.65             0.004
  rs9803679    1      178410425   OmniExpress   1 033   0.174   *RASAL2*         **5.21**   **0.027**      1.435        0.65             0.004
  rs2017349    1      178419417   OmniExpress   1 033   0.259   *RASAL2*         **5.38**   0.07           1.034        0.57             0.004
  rs12073428   1      178427933   OmniExpress   1 030   0.157   *RASAL2*         **4.98**   **7.40E-03**   1.829        0.682            0.006
  rs1008495    1      178458708   OmniExpress   1 029   0.19    Intergenic       **4.73**   0.065          1.134        0.613            0.004
  rs2252384    1      179785891   OmniExpress   1 033   0.242   Intergenic       **6.37**   0.095          −0.937       0.561            0.004
  rs2794579    1      179787027   OmniExpress   1 033   0.243   Intergenic       **6.12**   0.09           −0.965       0.568            0.004
  rs1148821    1      179795505   OmniExpress   1 033   0.24    Intergenic       **6.05**   0.095          −0.945       0.566            0.004
  rs2804699    1      181322837   Omni1S        1 026   0.351   Intergenic       **4.91**   0.49           0.353        0.515            0
  rs2804694    1      181331833   Omni1S        1 033   0.332   Intergenic       **4.55**   0.53           0.333        0.531            0.001

Boldface indicates LOD scores \> 3 or p-values \< 0.05.

###### 

Variants with LOD score \>4 and p-value \<0.005

  SNP          Chr   Position    N       MAF      Trait           Gene                            Variant          LOD    P-value    Beta Value   Variance
  ------------ ----- ----------- ------- -------- --------------- ------------------------------- ---------------- ------ ---------- ------------ ----------
  rs17109504   1     83468851    965     0.2363   ApoB            *.--.*                          unknown          4.08   3.99E-03   0.182        0.005
  rs10919343   1     170224982   1 032   0.205    AIR                                             unknown          4.32   0.003      1.86         0.012
  rs10494510   1     178074581   1 030   0.187    AIR             *RASAL2*                        intron           4.08   0.002      1.98         0.007
  rs6670912    1     178082410   1 033   0.187    AIR             *RASAL2*                        intron           4.28   0.0014     2.04         0.007
  rs4440820    1     178088698   1 034   0.186    AIR             *RASAL2*                        intron           4.18   0.0015     2.03         0.008
  rs12071903   1     178095804   1 034   0.187    AIR             *RASAL2*                        intron           4.22   0.0014     2.041        0.007
  rs10798597   1     178108248   1 032   0.185    AIR             *RASAL2*                        intron           4.01   0.0019     1.996        0.007
  rs10157702   1     178109045   1 033   0.186    AIR             *RASAL2*                        intron           4.28   0.0019     1.99         0.007
  rs10913513   1     178135941   1 034   0.186    AIR             *RASAL2*                        intron           4.08   0.0018     2.002        0.007
  rs2343249    4     62419426    1 017   0.3033   LDL             *LPHN3*                         intron           4.3    1.00E-05   −0.324       0.027
  rs13245847   7     38596983    821     0.431    TNF2            *AMPH*                          intron           4.14   5.20E-05   −0.056       0.019
  rs723968     9     14154231    820     0.2701   TNF2            *NFIB*                          intron           4.11   1.28E-03   −0.05        0.012
  rs7044402    9     14157468    821     0.2966   TNF2            *NFIB*                          intron           4.19   9.05E-04   −0.049       0.012
  rs16931436   9     14185939    821     0.2716   TNF2            *NFIB*                          intron           4.09   1.58E-03   −0.049       0.013
  rs10756748   9     16327712    1 029   0.313    HDL                                             unknown          4.1    0.0027     −0.039       0.013
  rs1939523    11    132599003   821     0.2954   TNF2            *OPCML*                         intron           4.01   3.13E-03   −0.046       0.006
  rs73202582   12    92044537    954     0.138    Adiponectin     *0*                             unknown          4.15   0.0019     −0.091       0.02
  rs9596564    13    33508797    1 029   0.2755   Triglycerides   *PDS5B (243392)-KL (81403)*     unknown          4.13   4.68E-03   −0.08        0.011
  rs11158243   14    20473910    821     0.316    TNF2                                            unknown          4.92   0.0037     −0.046       0.014
  rs11643893   16    16285847    784     0.425    Percent Fat     *ABCC6*                         intron           4.03   0.0034     −0.891       0.018
  rs11076039   16    54450940    1 024   0.466    HDL                                             unknown          5.43   0.0011     −0.039       0.007
  rs11645463   16    54456353    1 030   0.47     HDL                                             unknown          5.06   0.0049     −0.033       0.004
  rs5882       16    57016092    1 020   0.46     HDL             *CETP*                          Missense V422I   4.29   4.91E-04   0.042        0.012
  rs12602333   17    10169293    821     0.1681   TNF2            *GAS7 (245974)-MYH13 (34889)*   unknown          4.65   3.32E-03   −0.051       0.012
  rs17745091   17    52938797    785     0.498    Percent Fat                                     unknown          5.01   1.80E-04   1.156        0.014
  rs2332308    17    52944373    784     0.4802   Percent Fat     *.-TOM1L1 (33678)*              unknown          4.03   2.44E-04   1.141        0.01
  rs75500748   22    48739692    819     0.093    TNF2                                            unknown          4.21   2.70E-04   0.084        0.022

###### 

*LPHN3* Linkage and Association with LDL levels

  SNP          Chr   Position   Chip          N       MAF     LOD        P-value        Beta Value   Standard Error   Variance
  ------------ ----- ---------- ------------- ------- ------- ---------- -------------- ------------ ---------------- ----------
  rs17828264   4     62079015   Omni1S        1 021   0.5     1.17       0.44           −0.051       0.066            0
  rs17090416   4     62098937   OmniExpress   1 022   0.279   1.42       0.65           −0.034       0.074            0
  rs1505682    4     62111856   OmniExpress   1 022   0.315   1.44       0.22           −0.089       0.073            0.001
  rs1505670    4     62115243   Omni1S        1 021   0.475   1.26       0.69           −0.027       0.067            0
  rs13140257   4     62128750   Omni1S        999     0.321   1.66       **0.037**      −0.152       0.073            0.003
  rs11723103   4     62128825   Omni1S        1 019   0.375   1.33       0.052          −0.137       0.07             0.004
  rs1505663    4     62132090   OmniExpress   1 022   0.229   0.15       **7.90E-03**   0.213        0.08             0.003
  rs1505664    4     62132345   OmniExpress   1 020   0.371   1.42       **0.05**       −0.137       0.07             0.004
  rs67050759   4     62135455   Omni1S        1 019   0.496   1.49       0.12           −0.105       0.068            0.003
  rs74329144   4     62136292   Omni1S        1 022   0.055   1.02       0.076          0.263        0.148            0.002
  rs77082869   4     62254565   Omni1S        1 021   0.015   0.00       **1.77E-03**   0.896        0.287            0.013
  rs10008278   4     62366666   OmniExpress   1 018   0.092   1.28       0.096          0.2          0.12             0.003
  rs904243     4     62406445   OmniExpress   1 021   0.164   0.75       **6.49E-04**   −0.312       0.091            0.018
  rs7656189    4     62411676   OmniExpress   1 020   0.408   0.74       **4.07E-03**   0.2          0.069            0.013
  rs9312078    4     62412292   OmniExpress   1 015   0.331   **3.02**   **8.20E-05**   −0.282       0.071            0.022
  rs56905501   4     62413961   Omni1S        1 018   0.392   0.69       **2.98E-03**   0.207        0.07             0.014
  rs7688741    4     62416470   Omni1S        1 022   0.383   1.46       **2.11E-04**   −0.262       0.071            0.019
  rs2132074    4     62416499   OmniExpress   1 021   0.392   0.64       **1.86E-03**   0.216        0.069            0.014
  rs2343249    4     62419426   OmniExpress   1 017   0.303   **4.30**   **1.00E-05**   −0.324       0.073            0.027
  rs958862     4     62434848   OmniExpress   1 018   0.341   1.87       **3.60E-04**   −0.258       0.072            0.02
  rs10018746   4     62445246   Omni1S        1 021   0.5     0.97       **4.19E-03**   0.192        0.067            0.013
  rs11941524   4     62446484   Omni1S        1 022   0.5     0.86       **4.17E-03**   0.192        0.067            0.013
  rs2172802    4     62453209   Exome         1 012   0.45    0.50       **6.37E-03**   0.184        0.067            0.01
  rs17239080   4     62455462   OmniExpress   1 022   0.374   2.02       **2.32E-03**   −0.212       0.069            0.014
  rs11131334   4     62457454   OmniExpress   1 017   0.379   2.11       **4.84E-03**   −0.195       0.069            0.011
  rs1497901    4     62461940   OmniExpress   1 021   0.359   2.07       **1.77E-03**   −0.221       0.07             0.013
  rs2343250    4     62472682   Omni1S        1 022   0.36    2.09       **1.59E-03**   −0.224       0.071            0.013
  rs10001410   4     62474229   OmniExpress   1 019   0.47    0.91       **3.89E-03**   −0.199       0.069            0.016
  rs1497921    4     62526281   OmniExpress   1 022   0.356   0.64       **3.19E-03**   −0.204       0.069            0.014
  rs66614141   4     62550335   Omni1S        1 022   0.326   1.45       **1.35E-04**   −0.268       0.07             0.02
  rs6843311    4     62568688   OmniExpress   1 022   0.363   0.61       **5.25E-03**   −0.194       0.069            0.014
  rs11734607   4     62693692   OmniExpress   1 021   0.453   0.24       **2.44E-03**   0.204        0.067            0.015
  rs4860106    4     62850522   OmniExpress   1 021   0.422   1.13       0.71           0.025        0.068            0
  rs1510921    4     62895592   OmniExpress   1 017   0.241   0.26       **4.00E-03**   0.223        0.077            0.007
  rs6827266    4     62902162   Omni1S        1 020   0.437   0.08       **5.00E-03**   0.188        0.067            0.004
  rs62306380   4     62908281   Omni1S        1 022   0.239   0.23       **3.55E-03**   0.225        0.077            0.007

Boldface indicates LOD scores \> 3 or p-values \< 0.05.
